A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age < 65 and performance status 2

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7122 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7122-7122

Author(s):

J. F. Sandbach ◽

C. Weissman ◽

R. Brooker ◽

D. Ilegbodu ◽

L. Asmar

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Performance Status ◽

Stage Iv ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Weekly Docetaxel ◽

And Performance

Download Full-text

A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age < 65 and performance status 2

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7122 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7122-7122 ◽

Author(s):

J. F. Sandbach ◽

C. Weissman ◽

R. Brooker ◽

D. Ilegbodu ◽

L. Asmar

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Performance Status ◽

Stage Iv ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Weekly Docetaxel ◽

And Performance

Download Full-text

A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age <65 and performance status 2

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7276 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7276-7276

Author(s):

C. H. Weissman ◽

J. F. Sandbach ◽

R. J. Brooker ◽

D. Ilegbodu ◽

L. Asmar

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Performance Status ◽

Stage Iv ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Weekly Docetaxel ◽

And Performance

Download Full-text

Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age ≤65 and performance status 2

Lung Cancer ◽

10.1016/j.lungcan.2006.01.001 ◽

2006 ◽

Vol 52 (3) ◽

pp. 313-317 ◽

Author(s):

Charles H. Weissman ◽

John Sandbach ◽

Reginald Brooker ◽

Mark Vellek ◽

Deborah Lindquist ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Performance Status ◽

Stage Iv ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Weekly Docetaxel ◽

And Performance

Download Full-text

A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age <65 and performance status 2

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7276 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7276-7276

Author(s):

C. H. Weissman ◽

J. F. Sandbach ◽

R. J. Brooker ◽

D. Ilegbodu ◽

L. Asmar

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Performance Status ◽

Stage Iv ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Weekly Docetaxel ◽

And Performance

Download Full-text

CarVin versus CarEto - A randomised phase II study of carboplatin and vinorelbine versus carboplatin and etoposide in good performance status small cell lung cancer patients presenting with adverse prognostic factors

http://isrctn.org/> ◽

10.1186/isrctn44486227 ◽

2012 ◽

Author(s):

Ernie Marshall

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Performance Status ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

Case Medical Research ◽

10.31525/ct1-nct04253964 ◽

2020 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Pilot Study ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Clinical Benefit of Chemotherapy for Small-Cell Lung Cancer Patients with Extremely Poor Performance Status (PS)

Annals of Cancer Research and Therapy ◽

10.4993/acrt.26.1 ◽

2018 ◽

Vol 26 (1) ◽

pp. 1-6

Author(s):

Ou Yamaguchi ◽

Hiroshi Kagamu ◽

Atsuto Mouri ◽

Ayako Shiono ◽

Harue Utsugi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Clinical Benefit ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Annals of Oncology ◽

10.1093/annonc/mdm061 ◽

2007 ◽

Vol 18 (5) ◽

pp. 903-908 ◽

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

R. Buosi ◽

A. Masotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Stage Iv ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

MA15.07 Survival Benefit From Immunocheckpoint Inhibitors in Stage IV Non-small Cell Lung Cancer Patients ≥75 Years Old of Age

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.193 ◽

2021 ◽

Vol 16 (10) ◽

pp. S936

Author(s):

S. Takamori ◽

T. Komiya ◽

E. Powell

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Survival Benefit ◽

Stage Iv ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel

Annals of Oncology ◽

10.1093/annonc/mdh087 ◽

2004 ◽

Vol 15 (3) ◽

pp. 419-426 ◽

Author(s):

C. Gridelli ◽

A. Ardizzoni ◽

T. Le Chevalier ◽

C. Manegold ◽

F. Perrone ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell Lung ◽

Ecog Performance Status ◽

Lung Cancer Patients

Download Full-text